<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345486</url>
  </required_header>
  <id_info>
    <org_study_id>141349</org_study_id>
    <nct_id>NCT02345486</nct_id>
  </id_info>
  <brief_title>Isotonic Solution Administration Logistical Testing</brief_title>
  <acronym>SALT</acronym>
  <official_title>Isotonic Solution Administration Logistical Testing: Pilot Study for the Isotonic Solutions and Major Adverse Renal Events Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The administration of intravenous crystalloids is ubiquitous in the care of the critically
      ill. Commonly available crystalloid solutions contain a broad spectrum of electrolyte
      compositions including a range of chloride concentrations. Recent studies of associated
      higher fluid chloride content with acute kidney injury and mortality but no large, randomized
      trials have been conducted. In preparation for a large, cluster-randomized,
      multiple-crossover trial comparing 0.9% sodium chloride to physiologically-balanced isotonic
      crystalloids (Lactated Ringers or Plasmalyte-A) in intensive care unit patients, this pilot
      study will enroll all patients admitted to the medical intensive care unit at a single
      tertiary center for a sixth month period. The primary objective will be to test the ability
      of an electronic order entry tool to ensure administration of assigned study fluid or record
      contraindications to assigned study fluid. The pilot study will also demonstrate the
      feasibility of collecting demographic, severity of illness, fluid management, vital sign,
      laboratory, acute kidney injury and renal replacement therapy, and outcome data in an
      automated, electronic fashion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of Isotonic Crystalloid Which is 0.9% Saline</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is 0.9% sodium chloride, censored at 30 days. The primary outcome was the proportion of intravenous isotonic crystalloid administered in the ICU that was saline. This was a continuous variable calculated for each patient as the volume of saline received divided by volume of saline received plus volume of balanced crystalloids received with a range from 0.0 (no saline received) to 1.0 (only saline received).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of Isotonic Crystalloid Which is Physiologically Balanced</measure>
    <time_frame>30 days</time_frame>
    <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is either Lactated ringers or Plasmalyte-A, censored at 30 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Intravenous Input</measure>
    <time_frame>30 days</time_frame>
    <description>Total volume of intravenous fluid administration during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Isotonic Crystalloid Input</measure>
    <time_frame>30 days</time_frame>
    <description>Total volume of intravenous isotonic crystalloid administration during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Intravenous Colloid Input</measure>
    <time_frame>30 days</time_frame>
    <description>Total volume of intravenous colloid administration (excluding blood products) during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Intravenous Blood Product Administration</measure>
    <time_frame>30 days</time_frame>
    <description>Total volume of packed red blood cells, platelets, and fresh frozen plasma administered during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest Serum Chloride Between Enrollment and Day 30</measure>
    <time_frame>30 days</time_frame>
    <description>highest serum chloride (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest Serum Sodium Between Enrollment and Day 30</measure>
    <time_frame>30 days</time_frame>
    <description>Highest serum sodium concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest Bicarbonate Concentration Between Enrollment and Day 30</measure>
    <time_frame>30 days</time_frame>
    <description>Lowest serum bicarbonate concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With MAKE30</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of Major Adverse Kidney Events by 30 days -- a composite outcome defined as one or more of the following: death, new use of renal replacement therapy, or persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death prior to the earlier of hospital discharge or day 30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New Use of Renal Replacement Therapy</measure>
    <time_frame>30 days</time_frame>
    <description>Receipt of new renal replacement therapy after the first study day, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Renal Dysfunction</measure>
    <time_frame>30 days</time_frame>
    <description>Persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Contraindications</measure>
    <time_frame>30 days</time_frame>
    <description>Number of contraindications to assigned study fluid identified by providers, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hyperchloremia</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of hyperchloremia defined as a serum chloride greater than or equal to 110 mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Severe Hypochloremia</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of severe hypochloremia defined as a serum chloride less than 90mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in Serum Creatinine</measure>
    <time_frame>30 days</time_frame>
    <description>Increase in serum creatinine during hospitalization, censored at 30 days Change from baseline to highest value, median (IQR), mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Acute Kidney Injury</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of stage II or III acute kidney injury by Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury criteria, censored at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit Free Days to Day 28</measure>
    <time_frame>28 days</time_frame>
    <description>ICU-free days to 28 days after enrollment will be defined as the number of days alive and not admitted to an intensive care unit service after the patient's final discharge from the intensive care unit before 28 days. If the patient is admitted to an intensive care unit service at day 28 or dies prior to day 28, ICU-free days will be 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free Days (VFD) to Day 28</measure>
    <time_frame>28 days</time_frame>
    <description>Ventilator-free days to day 28 will be defined as the number of days alive and with unassisted breathing to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after initiating unassisted breathing and remains free of assisted breathing. If a patient returns to assisted breathing and subsequently achieves unassisted breathing prior to day 28, VFD will be counted from the end of the last period of assisted breathing to day 28. If the patient is receiving assisted ventilation at day 28 or dies prior to day 28, VFD will be 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dialysis-free Survival to Day 28</measure>
    <time_frame>28 days</time_frame>
    <description>Dialysis free survival to day 28 will be defined as the number of days alive and without dialysis receipt to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after last receipt of dialysis and remains free of dialysis. If the patient is receiving dialysis at day 28 or dies prior to day 28, VFD will be 0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Creatinine in the First 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Highest creatinine value in the first 30 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">974</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>0.9% sodium chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physiologically balanced fluid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.9% sodium chloride</intervention_name>
    <arm_group_label>0.9% sodium chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiologically balanced fluid</intervention_name>
    <arm_group_label>Physiologically balanced fluid</arm_group_label>
    <other_name>Lactated ringers or Plasmalyte-A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to the adult medical intensive care unit (MICU) at Vanderbilt University
             Medical Center

        Exclusion Criteria:

          -  Age&lt;18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd W Rice, M.D., M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, Gutteridge GA, Hart GK. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011 Nov;39(11):2419-24. doi: 10.1097/CCM.0b013e31822571e5.</citation>
    <PMID>21705897</PMID>
  </reference>
  <reference>
    <citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356.</citation>
    <PMID>23073953</PMID>
  </reference>
  <reference>
    <citation>Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, Setoguchi S, Beadles C, Lindenauer PK. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med. 2014 Jul;42(7):1585-91. doi: 10.1097/CCM.0000000000000305.</citation>
    <PMID>24674927</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <results_first_submitted>April 3, 2019</results_first_submitted>
  <results_first_submitted_qc>October 3, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 25, 2019</results_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Todd Rice</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Pilot Projects</keyword>
  <keyword>Plasmalyte A</keyword>
  <keyword>Ringer's lactate</keyword>
  <keyword>Sodium Chloride</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Resuscitation&quot;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasma-lyte 148</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This cluster-randomized, multiple-crossover trial enrolled 974 adults admitted to a tertiary medical intensive care unit from February 3, 2015 to May 31, 2015.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>0.9% Sodium Chloride</title>
          <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
        </group>
        <group group_id="P2">
          <title>Physiologically Balanced Fluid</title>
          <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="454"/>
                <participants group_id="P2" count="520"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="454"/>
                <participants group_id="P2" count="520"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>0.9% Sodium Chloride</title>
          <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
        </group>
        <group group_id="B2">
          <title>Physiologically Balanced Fluid</title>
          <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="454"/>
            <count group_id="B2" value="520"/>
            <count group_id="B3" value="974"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" lower_limit="46" upper_limit="70"/>
                    <measurement group_id="B2" value="57" lower_limit="44" upper_limit="68"/>
                    <measurement group_id="B3" value="58" lower_limit="45" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="208"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="460"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="268"/>
                    <measurement group_id="B3" value="514"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="454"/>
                    <measurement group_id="B2" value="520"/>
                    <measurement group_id="B3" value="974"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <description>Body mass index, median (IQR), kg/m2</description>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.4" lower_limit="22.4" upper_limit="32.8"/>
                    <measurement group_id="B2" value="26.7" lower_limit="22.5" upper_limit="32.5"/>
                    <measurement group_id="B3" value="26.6" lower_limit="22.5" upper_limit="32.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chronic kidney disease, stage III or greater</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous renal replacement therapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Source of ICU Admission</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Emergency Department</title>
                  <measurement_list>
                    <measurement group_id="B1" value="256"/>
                    <measurement group_id="B2" value="310"/>
                    <measurement group_id="B3" value="566"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Transfer from another hospital</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="199"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hospital ward</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="159"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Another ICU within the hospital</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Operating room</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Outpatient</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mechanical ventilation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="155"/>
                    <measurement group_id="B2" value="174"/>
                    <measurement group_id="B3" value="329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Vasopressors</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="114"/>
                    <measurement group_id="B3" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute kidney injury, stage II or greater</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Proportion of Isotonic Crystalloid Which is 0.9% Saline</title>
        <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is 0.9% sodium chloride, censored at 30 days. The primary outcome was the proportion of intravenous isotonic crystalloid administered in the ICU that was saline. This was a continuous variable calculated for each patient as the volume of saline received divided by volume of saline received plus volume of balanced crystalloids received with a range from 0.0 (no saline received) to 1.0 (only saline received).</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Isotonic Crystalloid Which is 0.9% Saline</title>
          <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is 0.9% sodium chloride, censored at 30 days. The primary outcome was the proportion of intravenous isotonic crystalloid administered in the ICU that was saline. This was a continuous variable calculated for each patient as the volume of saline received divided by volume of saline received plus volume of balanced crystalloids received with a range from 0.0 (no saline received) to 1.0 (only saline received).</description>
          <units>Percentage of fluid that was saline</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.2" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O2" value="21.0" lower_limit="0" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.70</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>0.74</ci_upper_limit>
            <estimate_desc>reported &quot;mean difference&quot; is a difference in proportions.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Isotonic Crystalloid Which is Physiologically Balanced</title>
        <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is either Lactated ringers or Plasmalyte-A, censored at 30 days.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Isotonic Crystalloid Which is Physiologically Balanced</title>
          <description>Proportion of total intravenous isotonic crystalloid administered during admission to the intensive care unit that is either Lactated ringers or Plasmalyte-A, censored at 30 days.</description>
          <units>Percentage of fluid that was balanced</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" lower_limit="0" upper_limit="100"/>
                    <measurement group_id="O2" value="78.8" lower_limit="0" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Intravenous Input</title>
        <description>Total volume of intravenous fluid administration during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Total Intravenous Input</title>
          <description>Total volume of intravenous fluid administration during admission to the intensive care unit, censored at 30 days</description>
          <units>milliliters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2000" lower_limit="792" upper_limit="4630"/>
                    <measurement group_id="O2" value="2125" lower_limit="1000" upper_limit="4625"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Isotonic Crystalloid Input</title>
        <description>Total volume of intravenous isotonic crystalloid administration during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Total Isotonic Crystalloid Input</title>
          <description>Total volume of intravenous isotonic crystalloid administration during admission to the intensive care unit, censored at 30 days</description>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1424" lower_limit="500" upper_limit="3377"/>
                    <measurement group_id="O2" value="1617" lower_limit="500" upper_limit="3628"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Intravenous Colloid Input</title>
        <description>Total volume of intravenous colloid administration (excluding blood products) during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Total Intravenous Colloid Input</title>
          <description>Total volume of intravenous colloid administration (excluding blood products) during admission to the intensive care unit, censored at 30 days</description>
          <units>milliliters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Intravenous Blood Product Administration</title>
        <description>Total volume of packed red blood cells, platelets, and fresh frozen plasma administered during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Total Intravenous Blood Product Administration</title>
          <description>Total volume of packed red blood cells, platelets, and fresh frozen plasma administered during admission to the intensive care unit, censored at 30 days</description>
          <units>milliliters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Highest Serum Chloride Between Enrollment and Day 30</title>
        <description>highest serum chloride (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Highest Serum Chloride Between Enrollment and Day 30</title>
          <description>highest serum chloride (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
          <units>mmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109" lower_limit="105" upper_limit="113"/>
                    <measurement group_id="O2" value="108" lower_limit="104" upper_limit="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Highest Serum Sodium Between Enrollment and Day 30</title>
        <description>Highest serum sodium concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Highest Serum Sodium Between Enrollment and Day 30</title>
          <description>Highest serum sodium concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
          <units>mmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141" lower_limit="139" upper_limit="144"/>
                    <measurement group_id="O2" value="141" lower_limit="138" upper_limit="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lowest Bicarbonate Concentration Between Enrollment and Day 30</title>
        <description>Lowest serum bicarbonate concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Lowest Bicarbonate Concentration Between Enrollment and Day 30</title>
          <description>Lowest serum bicarbonate concentration (mmol/L) during admission to the intensive care unit, censored at 30 days</description>
          <units>mmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" lower_limit="16" upper_limit="22"/>
                    <measurement group_id="O2" value="19" lower_limit="15" upper_limit="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With MAKE30</title>
        <description>Incidence of Major Adverse Kidney Events by 30 days -- a composite outcome defined as one or more of the following: death, new use of renal replacement therapy, or persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With MAKE30</title>
          <description>Incidence of Major Adverse Kidney Events by 30 days -- a composite outcome defined as one or more of the following: death, new use of renal replacement therapy, or persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                    <measurement group_id="O2" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In-hospital Mortality</title>
        <description>Death prior to the earlier of hospital discharge or day 30</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>In-hospital Mortality</title>
          <description>Death prior to the earlier of hospital discharge or day 30</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>New Use of Renal Replacement Therapy</title>
        <description>Receipt of new renal replacement therapy after the first study day, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>New Use of Renal Replacement Therapy</title>
          <description>Receipt of new renal replacement therapy after the first study day, censored at 30 days</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistent Renal Dysfunction</title>
        <description>Persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Persistent Renal Dysfunction</title>
          <description>Persistence of renal dysfunction at hospital discharge or at 30 days (defined as an increase in serum creatinine ≥ 200% from baseline)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Contraindications</title>
        <description>Number of contraindications to assigned study fluid identified by providers, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <population>Order for intravenous crystalloid is the unit analyzed; each patient could have multiple orders for intravenous crystalloid</population>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Contraindications</title>
          <description>Number of contraindications to assigned study fluid identified by providers, censored at 30 days</description>
          <population>Order for intravenous crystalloid is the unit analyzed; each patient could have multiple orders for intravenous crystalloid</population>
          <units>Orders for intravenous crystalloid</units>
          <param>Count of Units</param>
          <units_analyzed>Orders for intravenous crystalloid</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Orders for intravenous crystalloid</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="588"/>
                <count group_id="O2" value="854"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Hyperchloremia</title>
        <description>Incidence of hyperchloremia defined as a serum chloride greater than or equal to 110 mmol/L</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Hyperchloremia</title>
          <description>Incidence of hyperchloremia defined as a serum chloride greater than or equal to 110 mmol/L</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171"/>
                    <measurement group_id="O2" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Severe Hypochloremia</title>
        <description>Incidence of severe hypochloremia defined as a serum chloride less than 90mmol/L</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Severe Hypochloremia</title>
          <description>Incidence of severe hypochloremia defined as a serum chloride less than 90mmol/L</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Increase in Serum Creatinine</title>
        <description>Increase in serum creatinine during hospitalization, censored at 30 days Change from baseline to highest value, median (IQR), mg/dl</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Increase in Serum Creatinine</title>
          <description>Increase in serum creatinine during hospitalization, censored at 30 days Change from baseline to highest value, median (IQR), mg/dl</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" lower_limit="-0.1" upper_limit="0.5"/>
                    <measurement group_id="O2" value="0.07" lower_limit="-0.1" upper_limit="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Acute Kidney Injury</title>
        <description>Incidence of stage II or III acute kidney injury by Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury criteria, censored at 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Acute Kidney Injury</title>
          <description>Incidence of stage II or III acute kidney injury by Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury criteria, censored at 30 days</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                    <measurement group_id="O2" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intensive Care Unit Free Days to Day 28</title>
        <description>ICU-free days to 28 days after enrollment will be defined as the number of days alive and not admitted to an intensive care unit service after the patient's final discharge from the intensive care unit before 28 days. If the patient is admitted to an intensive care unit service at day 28 or dies prior to day 28, ICU-free days will be 0.</description>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Intensive Care Unit Free Days to Day 28</title>
          <description>ICU-free days to 28 days after enrollment will be defined as the number of days alive and not admitted to an intensive care unit service after the patient's final discharge from the intensive care unit before 28 days. If the patient is admitted to an intensive care unit service at day 28 or dies prior to day 28, ICU-free days will be 0.</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.1" lower_limit="22.1" upper_limit="26.2"/>
                    <measurement group_id="O2" value="25.2" lower_limit="21.8" upper_limit="26.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ventilator-free Days (VFD) to Day 28</title>
        <description>Ventilator-free days to day 28 will be defined as the number of days alive and with unassisted breathing to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after initiating unassisted breathing and remains free of assisted breathing. If a patient returns to assisted breathing and subsequently achieves unassisted breathing prior to day 28, VFD will be counted from the end of the last period of assisted breathing to day 28. If the patient is receiving assisted ventilation at day 28 or dies prior to day 28, VFD will be 0.</description>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Ventilator-free Days (VFD) to Day 28</title>
          <description>Ventilator-free days to day 28 will be defined as the number of days alive and with unassisted breathing to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after initiating unassisted breathing and remains free of assisted breathing. If a patient returns to assisted breathing and subsequently achieves unassisted breathing prior to day 28, VFD will be counted from the end of the last period of assisted breathing to day 28. If the patient is receiving assisted ventilation at day 28 or dies prior to day 28, VFD will be 0.</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.0" lower_limit="27.0" upper_limit="28.0"/>
                    <measurement group_id="O2" value="28.0" lower_limit="26.0" upper_limit="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dialysis-free Survival to Day 28</title>
        <description>Dialysis free survival to day 28 will be defined as the number of days alive and without dialysis receipt to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after last receipt of dialysis and remains free of dialysis. If the patient is receiving dialysis at day 28 or dies prior to day 28, VFD will be 0.</description>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Dialysis-free Survival to Day 28</title>
          <description>Dialysis free survival to day 28 will be defined as the number of days alive and without dialysis receipt to day 28 after enrollment, assuming a patient survives for at least two consecutive calendar days after last receipt of dialysis and remains free of dialysis. If the patient is receiving dialysis at day 28 or dies prior to day 28, VFD will be 0.</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.0" lower_limit="28.0" upper_limit="28.0"/>
                    <measurement group_id="O2" value="28.0" lower_limit="28.0" upper_limit="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Creatinine in the First 30 Days</title>
        <description>Highest creatinine value in the first 30 days</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0.9% Sodium Chloride</title>
            <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Physiologically Balanced Fluid</title>
            <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Creatinine in the First 30 Days</title>
          <description>Highest creatinine value in the first 30 days</description>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="454"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" lower_limit="0.81" upper_limit="2.30"/>
                    <measurement group_id="O2" value="1.19" lower_limit="0.80" upper_limit="2.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>0.9% Sodium Chloride</title>
          <description>Participants in the '0.9% sodium chloride' arm will receive 0.9% sodium chloride ('normal saline') any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
0.9% sodium chloride</description>
        </group>
        <group group_id="E2">
          <title>Physiologically Balanced Fluid</title>
          <description>Participants in the 'physiologically balanced fluid' arm will receive physiologically balanced fluid (Lactated ringers or Plasmalyte-A) any time an isotonic crystalloid is ordered by a provider during the intensive care unit admission.
Physiologically balanced fluid</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="454"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="520"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="454"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="520"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="454"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="520"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Matthew Semler</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>615-322-3412</phone>
      <email>matthew.w.semler@vumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

